Green light for cannabis research
CURTIN University is teaming up with a local company to develop a range of new medicinal cannabis products with the potential to deliver more accurate and targeted treatment for a range of medical conditions.
Curtin has provided an exclusive worldwide licence to Little Green Pharma for the micro-drug delivery system Arise (Atomised Rapid Injection for Solvent Extraction. It will use raw cannabis extract, provided by Little Green Pharma, in an 18-month development program to generate new medicinal cannabis formulations.
Arise developer and John Curtin Distinguished Emeritus Professor Neil Foster said the technology had the potential to deliver medicinal cannabis into a patient’s bloodstream more quickly and efficiently.
“Arise is a supercritical anti-solvent extraction technology which can potentially re-engineer the active pharmaceutical ingredients within cannabis into micro particles, meaning they can potentially be more easily absorbed into the bloodstream than conventional forms of the medicinal drug,” Prof Foster, from Western Australian
School of Mines: Minerals, Energy and Chemical Engineering, said.
“Better absorption means patients could potentially benefit by being prescribed lower doses for the same therapeutic effect.”
Little Green Pharma head of research and innovation Leon Warne said it was an exciting opportunity for Australia’s first locally grown medicinal cannabis producer.
“Arise has the potential to significantly improve the accuracy of delivery and easeof-dosing for patients prescribed medicinal cannabis,” Dr Warne said.
Professor Neil Foster and Dr Leon Warne.